DeepSeek use halted across Belgium
DeepSeek, a project to screen COVID-19 patients for mutational variants, has been suspended in Belgium due to an issue with a supplier.
The announcement was made on the project's website, stating that the issue has caused a halt in the project's activities.
DeepSeek has been conducting tests on patients with COVID-19 to identify any potential mutations that could lead to the virus becoming more transmissible or resistant to vaccines.
The project has been ongoing since 2020 and has screened thousands of patients across Belgium. However, the issue with the supplier has forced the project to temporarily halt its activities.
The exact nature of the issue with the supplier has not been disclosed, but it is believed to be related to a problem with the testing kits used in the project.
The suspension of DeepSeek has raised concerns among experts and healthcare professionals, who are worried about the potential impact on the fight against COVID-19.
However, the project's team has assured that the suspension is temporary and that they are working to resolve the issue as quickly as possible.
DeepSeek is a collaborative project between several Belgian universities and research institutions, and it has received funding from the Belgian government.
In a statement, the project's team said:
“We are deeply sorry for the inconvenience this has caused and are working closely with our partners to resolve the issue as quickly as possible. We will provide updates on our website as soon as possible.”
Resumé: The DeepSeek project has been temporarily halted in Belgium due to an issue with a supplier, causing concerns among experts and healthcare professionals.